Cefoprox CV 50 mg/31.25 mg Dry Syrup belongs to the group of medicines called antibiotics used to treat various bacterial infections such as pharyngitis/tonsillitis (throat infections), otitis media (ear infections), sinusitis (infection of the sinuses), community-acquired pneumonia, gonorrhoea (sexually transmitted disease), anorectal infections in women, skin, and urinary tract infections. Bacterial infections are caused due to the multiplication of harmful bacteria inside or on the body. 

Cefoprox CV 50 mg/31.25 mg Dry Syrup is a combination of two antibiotics, Cefpodoxime proxetil (cephalosporin antibiotic) and Clavulanic acid (beta-lactamase inhibitor). Cefpodoxime proxetil works by preventing the formation of bacterial cell covering, which is necessary for their survival. Thus, it kills the bacteria. Clavulanic acid works by decreasing bacterial resistance and enhancing the activity of Cefpodoxime proxetil against the bacteria. Together, Cefoprox CV 50 mg/31.25 mg Dry Syrup helps to treat bacterial infections.

Take Cefoprox CV 50 mg/31.25 mg Dry Syrup as prescribed by the doctor. The dose and duration of Cefoprox CV 50 mg/31.25 mg Dry Syrup can vary depending on your condition and the severity of the infection. In some cases, you may experience certain common side effects such as diarrhoea, abdominal pain, nausea, and vomiting. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects persistently.

Before starting Cefoprox CV 50 mg/31.25 mg Dry Syrup, please inform your doctor if you have any allergy to any antibiotic or kidney or liver problems. Consult your doctor before taking Cefoprox CV 50 mg/31.25 mg Dry Syrup if you are pregnant or planning for pregnancy. Avoid taking Cefoprox CV 50 mg/31.25 mg Dry Syrup if you are breastfeeding as Cefoprox CV 50 mg/31.25 mg Dry Syrup may pass into breast milk. Avoid alcohol consumption while taking Cefoprox CV 50 mg/31.25 mg Dry Syrup to prevent unpleasant side effects. Cefoprox CV 50 mg/31.25 mg Dry Syrup may cause dizziness, so drive with caution.

• Cefoprox CV 50 mg/31.25 mg Dry Syrup can be taken with food to enhance absorption and reduce the risk of stomach upset.
• Follow your doctor’s recommendations on the dosage and timing of this medication to achieve optimal results.
• Swallow Cefoprox CV 50 mg/31.25 mg Dry Syrup as a whole with a glass of water.
• Do not crush, chew, or break it.

Cefoprox CV 50 mg/31.25 mg Dry Syrup belongs to the group of medicines called antibiotics used to treat various bacterial infections such as pharyngitis/tonsillitis (throat infections), otitis media (ear infections), sinusitis (infection of the sinuses), community-acquired pneumonia, gonorrhoea (sexually transmitted disease), anorectal infections in women, skin, and urinary tract infections. Cefoprox CV 50 mg/31.25 mg Dry Syrup is a combination of two antibiotics: Cefpodoxime proxetil (cephalosporin antibiotic) and Clavulanic acid (beta-lactamase inhibitor). Cefpodoxime proxetil works by preventing the formation of bacterial cell covering, which is necessary for their survival. Thus, it kills the bacteria. Clavulanic acid works by decreasing bacterial resistance and enhancing the activity of Cefpodoxime proxetil against the bacteria. Together, Cefoprox CV 50 mg/31.25 mg Dry Syrup helps to treat bacterial infections. Cefoprox CV 50 mg/31.25 mg Dry Syrup is a broad-spectrum antibiotic that is effective against both gram-positive and gram-negative bacteria, including beta-lactamase-producing strains.

Before starting Cefoprox CV 50 mg/31.25 mg Dry Syrup, please inform your doctor if you have any allergy to any antibiotic or kidney or liver problems. Cefoprox CV 50 mg/31.25 mg Dry Syrup should not be given to patients with rare hereditary problems of galactose intolerance (the Lapp lactase deficiency or glucose-galactose malabsorption). Consult your doctor before taking Cefoprox CV 50 mg/31.25 mg Dry Syrup if you have colitis (colon inflammation), if you are pregnant or planning for pregnancy. Avoid taking Cefoprox CV 50 mg/31.25 mg Dry Syrup if you are breastfeeding, as it may pass into breast milk. Avoid alcohol consumption while taking Cefoprox CV 50 mg/31.25 mg Dry Syrup to prevent unpleasant side effects. Cefoprox CV 50 mg/31.25 mg Dry Syrup causes dizziness, so drive with caution.